Historical Valuation
Novocure Ltd (NVCR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.14 is considered Undervalued compared with the five-year average of -8.38. The fair price of Novocure Ltd (NVCR) is between 14.97 to 120.23 according to relative valuation methord. Compared to the current price of 14.35 USD , Novocure Ltd is Undervalued By 4.15%.
Relative Value
Fair Zone
14.97-120.23
Current Price：14.35
4.15%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Novocure Ltd (NVCR) has a current Price-to-Book (P/B) ratio of 4.30. Compared to its 3-year average P/B ratio of 7.13 , the current P/B ratio is approximately -39.66% higher. Relative to its 5-year average P/B ratio of 15.59, the current P/B ratio is about -72.40% higher. Novocure Ltd (NVCR) has a Forward Free Cash Flow (FCF) yield of approximately -4.44%. Compared to its 3-year average FCF yield of -3.98%, the current FCF yield is approximately 11.34% lower. Relative to its 5-year average FCF yield of -2.14% , the current FCF yield is about 106.89% lower.
P/B
Median3y
7.13
Median5y
15.59
FCF Yield
Median3y
-3.98
Median5y
-2.14
Competitors Valuation Multiple
AI Analysis for NVCR
The average P/S ratio for NVCR competitors is 4.14, providing a benchmark for relative valuation. Novocure Ltd Corp (NVCR.O) exhibits a P/S ratio of 2.14, which is -48.33% above the industry average. Given its robust revenue growth of 7.81%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for NVCR
1Y
3Y
5Y
Market capitalization of NVCR increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of NVCR in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is NVCR currently overvalued or undervalued?
Novocure Ltd (NVCR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.14 is considered Undervalued compared with the five-year average of -8.38. The fair price of Novocure Ltd (NVCR) is between 14.97 to 120.23 according to relative valuation methord. Compared to the current price of 14.35 USD , Novocure Ltd is Undervalued By 4.15% .
What is Novocure Ltd (NVCR) fair value?
NVCR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Novocure Ltd (NVCR) is between 14.97 to 120.23 according to relative valuation methord.
How does NVCR's valuation metrics compare to the industry average?
The average P/S ratio for NVCR's competitors is 4.14, providing a benchmark for relative valuation. Novocure Ltd Corp (NVCR) exhibits a P/S ratio of 2.14, which is -48.33% above the industry average. Given its robust revenue growth of 7.81%, this premium appears unsustainable.
What is the current P/B ratio for Novocure Ltd (NVCR) as of Jan 10 2026?
As of Jan 10 2026, Novocure Ltd (NVCR) has a P/B ratio of 4.30. This indicates that the market values NVCR at 4.30 times its book value.
What is the current FCF Yield for Novocure Ltd (NVCR) as of Jan 10 2026?
As of Jan 10 2026, Novocure Ltd (NVCR) has a FCF Yield of -4.44%. This means that for every dollar of Novocure Ltd’s market capitalization, the company generates -4.44 cents in free cash flow.
What is the current Forward P/E ratio for Novocure Ltd (NVCR) as of Jan 10 2026?
As of Jan 10 2026, Novocure Ltd (NVCR) has a Forward P/E ratio of -8.92. This means the market is willing to pay $-8.92 for every dollar of Novocure Ltd’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Novocure Ltd (NVCR) as of Jan 10 2026?
As of Jan 10 2026, Novocure Ltd (NVCR) has a Forward P/S ratio of 2.14. This means the market is valuing NVCR at $2.14 for every dollar of expected revenue over the next 12 months.